Trade ARK Genomic Revolution ETF - ARKG CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.13
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.021485 %(-$4.30)Trade size with leverage ~ $20,000.00Money from leverage ~ $$19,000.00Go to platform: -0.02149%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.000738 %(-$0.15)Trade size with leverage ~ $20,000.00Money from leverage ~ $$19,000.00Go to platform: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.021485 %
  (-$4.30)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000738 %
  (-$0.15)

Key Stats

• Prev. Close: 42.51
• Open: 41.64
• 1-Year Change: 71.43%
• Day's Range: 40.68 - 41.77

Trade ARK Genomic Revolution ETF - ARKG

ARK Genomic Revolution ETF (ARKG) is an actively managed exchange-traded fund (ETF) that seeks long-term capital growth through investment in the genomics revolution. 

Launched in 2014 by ARK Investment Management LLC, ARKG has $3.69bn of assets under management (AUM).

Under normal circumstances, the fund invests at least 80% of its assets in domestic and foreign equity securities in companies that justify the fund’s theme and focus on enhancing the quality of life with a better lifestyle and increased longevity. 

Coming from various sectors such as healthcare, information technology and materials, these companies incorporate technological and scientific developments in genomics into their businesses.

As of June 2022, the fund’s portfolio had the highest exposure to molecular diagnostics, followed by bioinformatics, beyond DNA, targeted therapeutics, gene therapy and agricultural biology. 

Listed on the Better Alternative Trading System (BATS), ARK Genomic Revolution ETF trades under the ticker symbol ARKG. The fund pays dividends annually. 

You can follow ARKG share value at Capital.com, and stay on top of the latest price developments with our live ARK Genomic Revolution (ARKG) chart.